The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression.
Anxiety is integrated in the amygdaloid nuclei and involves the interplay of the amygdala and various other areas of the brain. Neuropeptides play a critical role in regulating this process. Neuropeptide Y (NPY), a 36 aa peptide, is highly expressed in the amygdala. It exerts potent anxiolytic effects through cognate postsynaptic Y1 receptors, but augments anxiety through presynaptic Y2 receptors. To identify the precise anatomical site(s) of Y2-mediated anxiogenic action, we investigated the effect of site-specific deletion of the Y2 gene in amygdaloid nuclei on anxiety and depression-related behaviors in mice. Ablating the Y2 gene in the basolateral and central amygdala resulted in an anxiolytic phenotype, whereas deletion in the medial amygdala or in the bed nucleus of the stria terminalis had no obvious effect on emotion-related behavior. Deleting the Y2 receptor gene in the central amygdala, but not in any other amygdaloid nucleus, resulted in an added antidepressant-like effect. It was associated with a reduction of presumably presynaptic Y2 receptors in the stria terminalis/bed nucleus of the stria terminalis, the nucleus accumbens, and the locus ceruleus. Our results are evidence of the highly site-specific nature of the Y2-mediated function of NPY in the modulation of anxiety- and depression-related behavior. The activity of NPY is likely mediated by the presynaptic inhibition of GABA and/or NPY release from interneurons and/or efferent projection neurons of the basolateral and central amygdala.
Tasan
Ramon O
RO
Department of Pharmacology, Medical University Innsbruck, 6020 Innsbruck, Austria. ramon.tasan@i-med.ac.at
Nguyen
Ngoc Khoi
NK
Weger
Stefan
S
Sartori
Simone B
SB
Singewald
Nicolas
N
Heilbronn
Regine
R
Herzog
Herbert
H
Sperk
Günther
G
D000679:Amygdala / Q000378:metabolism / Q000502:physiology*; D000818:Animals; D001007:Anxiety / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D003863:Depression / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D004195:Disease Models, Animal; D008125:Locus Coeruleus / Q000378:metabolism; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009478:Neuropeptide Y / Q000378:metabolism / Q000502:physiology*; D017476:Receptors, Neuropeptide Y / Q000235:genetics* / Q000502:physiology*; D012686:Septal Nuclei / Q000378:metabolism / Q000502:physiology
D009478:Neuropeptide Y; D017476:Receptors, Neuropeptide Y; C095889:neuropeptide Y2 receptor
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2320-5
11842206
Pharmacol Biochem Behav. 2002 Mar;71(3):419-23
11830176
Pharmacol Biochem Behav. 1980 Aug;13(2):167-70
6106204
Psychopharmacology (Berl). 1985;85(3):367-70
3923523
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
15939837
Methods. 2002 Oct;28(2):158-67
12413414
Mol Cell Neurosci. 2008 Nov;39(3):491-8
18790060
Psychopharmacology (Berl). 2008 Jan;195(4):547-57
17891380
Trends Neurosci. 1998 Aug;21(8):323-31
9720596
J Neurosci. 1996 Dec 1;16(23):7711-24
8922427
Ann N Y Acad Sci. 2003 Apr;985:185-205
12724159
Psychopharmacology (Berl). 1987;92(2):180-5
3110839
Behav Brain Res. 2003 May 15;141(2):251-5
12742262
Horm Behav. 1997 Jun;31(3):197-211
9213134
Prog Neurobiol. 2003 Jun;70(2):83-244
12927745
J Neurosci. 2008 Feb 6;28(6):1374-84
18256257
Neurosci Biobehav Rev. 2001 May;25(3):261-73
11378180
Neurosci Lett. 1989 May 22;100(1-3):53-8
2569703
Brain Res Brain Res Rev. 2001 Dec;38(1-2):79-128
11750928
J Chem Neuroanat. 2000 Dec;20(3-4):327-37
11207429
Eur J Neurosci. 2003 Jul;18(1):143-8
12859347
Neuropharmacology. 2006 Oct;51(5):1013-22
16904135
Br J Pharmacol. 1991 Jan;102(1):41-4
1646061
J Neurosci. 1988 Jul;8(7):2517-29
2854842
J Neurosci. 1993 Jan;13(1):73-86
8423484
J Neurosci. 2001 Aug 1;21(15):5804-12
11466452
Neuroscience. 2009 Feb 18;158(4):1717-30
19121371
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4280-5
15024126
J Comp Neurol. 2006 Nov 20;499(3):357-90
16998904
Neuropsychopharmacology. 1993 Jun;8(4):357-63
8099792
Regul Pept. 1995 Oct 20;59(2):201-5
8584755
Peptides. 2006 Dec;27(12):3202-7
16959374
Brain Res. 1989 Oct 23;500(1-2):37-45
2575006
Brain Res. 2000 Jun 16;868(1):79-87
10841890
Peptides. 1998;19(2):359-63
9493869
J Neurochem. 1991 Feb;56(2):525-30
1988555
Brain Res Brain Res Rev. 2001 Dec;38(1-2):192-246
11750933
Science. 1993 Jan 22;259(5094):528-31
8380941
Brain Res. 2005 Feb 21;1035(1):24-31
15713273
J Psychopharmacol. 2008 Aug;22(6):633-41
18308797
Mol Ther. 2003 Jun;7(6):839-50
12788658
J Comp Neurol. 1986 Sep 15;251(3):349-62
2429995
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8938-43
12072562
Psychopharmacology (Berl). 1989;97(2):277-9
2567028
Behav Pharmacol. 1995 Apr;6(3):215-222
11224329
Ann N Y Acad Sci. 2003 Apr;985:1-21
12724144